Abbott Laboratories

ABTNYSE • USD
97.50 USD
↗ 0.81 (0.84%)AT CLOSE (03:59 PM EDT)
97.40
↘ 0.10 (0.10%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
97.40
↘ 0.10 (0.10%)
🔴Market: CLOSED

ABT is currently priced at $97.50. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, ABT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 2, 2026.

Open?$97.25
High?$97.59
Low?$95.06
Prev. Close?$96.69
Volume?8.7M
Avg. Volume?8.5M
VWAP?$96.86
Rel. Volume?1.03x
Bid / Ask
Bid?$97.00 × 500
Ask?$97.80 × 700
Spread?$0.80
Midpoint?$97.40
Valuation & Ratios
Market Cap?168.7B
Shares Out?1.7B
Float?1.7B
Float %?99.6%
P/E Ratio?31.10
P/B Ratio?3.30
EPS?$3.14
Dividend?2.53%
Ex-Dividend?2026-10-15
News
Profile
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Employees
115.0K
Market Cap
168.7B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-19
Address
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
Phone: (224) 667-6100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
75
Momentum?
21
Short Sent.?
89
Piotroski F-Score?3/9Weak
Altman Z-Score?3.12Safe
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.16%Low
Short Interest?19.9M
Days to Cover?2.6
Free Float1.7B
Avg Daily Volume7.7M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.38Adequate
Quick Ratio?0.97Weak
Cash Ratio?0.29Low
Debt/Equity?0.64Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
61/100
P/E?
Peers
64
S&P
31
31.1PRICEY▾
P/B?
Peers
50
S&P
51
3.30FAIR▾
P/S?
Peers
55
S&P
42
3.62FAIR▾
P/FCF?
Peers
64
S&P
50
21.6FAIR▾
EV/EBITDA?
Peers
45
S&P
33
18.2FAIR▾
EV/Sales?
Peers
55
S&P
44
4.21FAIR▾
Returns & Efficiency
ROE?
Peers
40
S&P
37
10.6%FAIR▾
ROA?
Peers
45
S&P
45
5.0%FAIR▾
Cash Flow & Enterprise
FCF?$7.8B
Enterprise Value?$196.2B
Fundamentals ratios updated end of day